Pere Santamaria Selected Research

Glucose-6-Phosphatase (Glucose 6 Phosphatase)

11/2013	DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8⁺ T cells independently of PD-1 and PD-L1.
9/2012	Autoantigen recognition is required for recruitment of IGRP(206-214)-autoreactive CD8+ T cells but is dispensable for tolerance.
1/2010	Idd9.1 locus controls the suppressive activity of FoxP3+CD4+CD25+ regulatory T-cells.
8/2009	Spontaneous autoimmunity sufficiently potent to induce diabetes mellitus is insufficient to protect against insulinoma.
7/2006	Modeling competition among autoreactive CD8+ T cells in autoimmune diabetes: implications for antigen-specific therapy.
6/2005	Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pere Santamaria Research Topics

Disease

38	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2021 - 02/2002
29	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2003
10	Inflammation (Inflammations) 01/2021 - 02/2003
5	Neoplasms (Cancer) 01/2020 - 08/2009
3	COVID-19 01/2021 - 01/2021
3	Infections 01/2019 - 05/2010
3	Disease Progression 06/2008 - 07/2006
2	Common Cold 01/2021 - 01/2021
2	Autoimmune Hepatitis 11/2020 - 01/2019
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2020 - 01/2020
2	Contact Dermatitis (Eczema, Contact) 06/2008 - 05/2004
1	Reinfection 01/2021
1	Muscle Cramp (Cramp) 01/2021
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2019
1	Sclerosing Cholangitis 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2017
1	Colitis 10/2017
1	Rheumatoid Arthritis 10/2013
1	Multiple Sclerosis 10/2013
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2013
1	Disease Resistance 02/2013
1	Insulinoma 08/2009
1	Insulin Resistance 12/2006
1	Crohn Disease (Crohn's Disease) 06/2006
1	Arthritis (Polyarthritis) 06/2006
1	Diabetes Mellitus 06/2006
1	Starvation 06/2006
1	Myotonic Dystrophy (Dystrophia Myotonica) 12/2004
1	Prediabetic State (Prediabetes) 02/2003
1	Endotoxemia 07/2002

Drug/Important Bio-Agent (IBA)

23	AntigensIBA 01/2022 - 02/2002
15	Insulin (Novolin)FDA Link 11/2021 - 01/2003
15	Peptides (Polypeptides)IBA 10/2021 - 01/2003
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2005
8	CytokinesIBA 01/2021 - 01/2003
7	AutoantigensIBA 01/2021 - 08/2009
6	EpitopesIBA 11/2020 - 06/2005
6	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 11/2013 - 06/2005
5	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2010 - 02/2003
3	Interleukin-2 (IL2)IBA 10/2016 - 03/2007
3	Histocompatibility Antigens Class IIIBA 07/2013 - 02/2002
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2021 - 01/2018
2	AntibodiesIBA 01/2021 - 01/2021
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2015 - 02/2012
2	AutoantibodiesIBA 12/2013 - 02/2003
2	InterleukinsIBA 01/2012 - 03/2007
2	Interleukin-1 (Interleukin 1)IBA 01/2012 - 06/2006
2	LigandsIBA 06/2005 - 01/2003
2	ChemokinesIBA 05/2004 - 01/2003
1	Dual-Specificity PhosphatasesIBA 11/2021
1	VaccinesIBA 01/2021
1	Bulk DrugsIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	NucleotidesIBA 01/2021
1	cathelinIBA 01/2021
1	Explosive Agents (Explosives)IBA 01/2021
1	CathelicidinsIBA 01/2021
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 11/2020
1	IntegrinsIBA 10/2017
1	PerforinIBA 10/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	ProlactinIBA 01/2016
1	NanovaccinesIBA 01/2015
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2013
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 06/2012
1	C-PeptideIBA 06/2012
1	HLA-A*02:01 antigenIBA 06/2012
1	Type I Tumor Necrosis Factor ReceptorsIBA 08/2011
1	Glucose (Dextrose)FDA LinkGeneric 08/2011
1	Streptozocin (Streptozotocin)FDA Link 04/2008
1	ProinsulinIBA 04/2008
1	Adenosine DeaminaseIBA 08/2007
1	Adenosine (Adenocard)FDA LinkGeneric 08/2007
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 06/2007
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 06/2007
1	Hormones (Hormone)IBA 06/2007
1	Substance PIBA 12/2006
1	NeuropeptidesIBA 12/2006
1	Blood Glucose (Blood Sugar)IBA 06/2006
1	Tryptophan (L-Tryptophan)FDA Link 06/2006
1	Peptide LibraryIBA 12/2004
1	Phosphotransferases (Kinase)IBA 12/2004
1	SelectinsIBA 05/2004
1	Glycoproteins (Glycoprotein)IBA 02/2003
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2002

Therapy/Procedure

5	Therapeutics 01/2019 - 07/2006
3	Immunotherapy 01/2016 - 01/2015
1	Transplantation 04/2008
1	Intra-Arterial Injections 12/2006